FMCG & Food · Household/Personal Care · NSE: MEDISTEP · data 2026-10-30

Medistep Healthcare Limited

₹19.5+4.00% on 30 OctHealth: Strong 7.5/10

In plain words

Price: 35.0% below its 52-week high of ₹30.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹19.5

Market cap

₹27 cr

P/E

4.6

P/B

0.7

ROE

21.7%

ROCE

29.8%

Debt / equity

0.14

Dividend yield

0.00%

1-year return

-25.9%

52-week high

₹30

52-week low

₹16.5

Operating margin

11.6%

Growth

Revenue (last 12 months)	₹71 cr
Net profit (last 12 months)	₹6 cr
Sales growth, 3 years (yearly)	36.8%
Profit growth, 3 years (yearly)	86.6%

Smart-money activity

5/100 · Weak over the last ~60 sessions

Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
Promoter pledges 5/5: No promoter pledge filings in 90 days.

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Medistep Healthcare Limited debt-free?

Its latest reported debt-to-equity ratio is 0.14.

What is Medistep Healthcare Limited's P/E ratio?

About 4.6, based on the last 12 months' earnings and a price of ₹19.5 (data 2026-10-30).

What is the 52-week high and low of Medistep Healthcare Limited?

The 52-week high is ₹30 and the 52-week low is ₹16.5.

Similar companies

Bajaj Consumer Care Limited (BAJAJCON) · Sacheerome Limited (SACHEEROME) · Kaya Limited (KAYA) · Dhariwalcorp Limited (DHARIWAL) · JHS Svendgaard Laboratories Limited (JHS)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open MEDISTEP in NSE Scanner →